NYU Langone Health initiates osseointegration program based on Integrum’s OPRA[TM] Implant System
Mölndal, Sweden, December 1[st], 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that NYU Langone Health has completed its first patient treatment using the OPRA[TM] Implant System, marking the initiation of NYU Langone’s Center for Amputation Reconstruction’s Osseointegration Program which will be added to the center’s expertise in treatment of limb loss. Furthermore, OPRA[TM ]Implant System will be offered as part of an Osseointegration Program for Bone Cancer patients at the Perlmutter Cancer Center, a part of the NYU Langone Health Center.NYU Langone